Allworth Financial LP Spectrum Pharmaceuticals Inc Transaction History

Allworth Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$0.38 - $1.07 $76 - $214	200 Added 16.81%	1,390 $1,000
Q4 2022 Jan 13, 2023	BUY	$0.32 - $0.52 $380 - $618	1,190 New	1,190 $0
Q2 2022 Jul 13, 2022	BUY	$0.7 - $1.4 $798 - $1,596	1,140 New	1,140 $1,000
Q3 2021 Nov 02, 2021	SELL	$2.15 - $3.82 $715 - $1,272	-333 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$2.89 - $4.45 $962 - $1,481	333 New	333 $1,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.